Here is a thing about the financial industry that is both obvious and, once you notice it, a little absurd. For roughly a century, the tools that told people how much to save and how to invest were built on a set of default assumptions - about lifespan, about career arcs, about paychecks - and those defaults quietly described the median man. This was not a conspiracy. It was just easier. Everyone knew women lived longer and earned less; the models simply did not do anything about it. The disclosure was in the footnote and the footnote was in a language nobody read.

Ellevest's founding idea is to move the footnote into the algorithm. Co-founded in 2014 by Sallie Krawcheck and Charlie Kroll, and launched to the public in 2016, the company built a gender-aware investing platform whose starting assumptions are that a woman will probably live several years longer than a comparable man, will likely hit peak earnings about a decade earlier, and will earn less along the way. Feed those facts into a goal-based model and you get different advice out the other end - often, uncomfortably, the advice to save more.

This is a good business idea for a boring reason: the market is enormous and had been labeled "niche." Women are half the population and a fast-growing share of the wealth, yet financial products treated them as an edge case to be handled with a pink brochure. Krawcheck's insight was that the edge case was the market. If you build the product for the customer the industry overlooks, you do not have to fight for the customer everyone else is fighting for.

It helps that the founder was not an outsider throwing stones. Krawcheck had run wealth management at both Merrill Lynch and Citi - about as far inside Wall Street as a person can get - and was once dubbed "the last honest analyst." She left the top of the industry to build for the customer the industry kept losing. The most credible critic of a system is usually someone who ran a large part of it.

Ellevest's second insight was that you cannot fix what you refuse to measure. In 2022 it launched the Ellevest Women's Financial Health Index, which folds together the pay gap, inflation, student debt, paid family leave and reproductive rights into a single read on how women are actually doing financially. The first finding was grim - a five-year low - which is exactly the sort of number a company like this exists to surface. It is hard to lobby for change against a vibe. It is easier against an index.

The money followed the thesis, and did so in a way that was itself part of the pitch. Ellevest's $53 million Series B in April 2022, co-led by BMO and Contour Venture Partners, was notable less for the size than for the cap table: roughly 90% of the investors were women or from underrepresented groups, and some 360 of them supplied about two-thirds of the total. A company built for women, funded largely by women. If you want to change who capital serves, it does not hurt to change who controls the capital.

Then, in 2025, Ellevest did the thing that looks like a retreat and is actually a decision. It sold its automated-investing business - the robo-advisor, the low-fee digital product that made it famous - to Betterment, which absorbed the accounts and the assets but not the people, the tech, or the brand. Ellevest kept the harder, higher-trust half: wealth management and financial planning delivered by an all-women team of Certified Financial Planners and Chartered Financial Analysts, for clients investing $500,000 or more.

The logic is the unglamorous logic of trust businesses everywhere. Automation scales reach; relationships scale wealth. Serving a million people a little tends to make less money, and less durable money, than serving fewer people deeply. Selling the product that put you on the map to focus on the one that pays the rent is one of the harder calls a founder makes, and Ellevest made it during a leadership transition, too - Krawcheck stepped down as CEO in late 2024 for health reasons, handing the company to co-CEOs Dr. Sylvia Kwan and Connie Hsiung. Succession is the real test of whether a mission outlives the person who started it.